Nasal spray composition for COVID-19 and SARS and method of forming the same
AssigneeCoFix-RX, LLC
InventorsRavi Hedni, Karen Raehtz, Dennis G Kaiser, Andrew Krause
Life of this patent
Estimating the term…
Abstract
A nasal spray solution of the present invention includes a Povidone iodine solution; a Vitamin D liquid, Polysorbate 80 nf, Xylitol NF, water sterile, Sodium hydroxide 10% solution, and Polysaccharide 1% solution, wherein 1% solution further includes a gellan gum and a carrageenan, used as carriers to deliver liquids to cells of human and act as entrapment within a polymeric coating to block virus uptake into the cells, inactivate the virus, and protect a lining of an upper respiratory pathways against COVID-19 and SARS.
Claims12
A liquid nasal spray composition to treat a viral respiratory infectious disease, the nasal spray composition comprising:
- a first component comprising an iodophor solution that includes iodine and povidone;
- a second component comprising a liquid form of Vitamin D;
- a third component comprising Polysorbate 80 nf;
- a fourth component comprising Xylitol NF;
- a fifth component comprising sterile water;
- a sixth component comprising a 10% solution of sodium hydroxide;
- and
- a seventh component comprising a 1% solution of Polysaccharide;
- the 1% solution of Polysaccharide including a gellan gum and a carrageenan;
- wherein the first, second, third, fourth, sixth and seventh components are added and dissolved in the fifth component to produce the liquid nasal spray composition.
A liquid nasal spray composition to treat a viral respiratory infectious disease, the nasal spray composition comprising:
- a first component comprising an iodophor solution in an amount of 12.5 ml, wherein the iodophor solution includes iodine and povidone;
- a second component comprising a liquid form of Vitamin D in an amount of 1 gram;
- a third component comprising Polysorbate 80 nf in an amount of 1 ml;
- a fourth component comprising Xylitol NF in an amount of 5 grams;
- a fifth component comprising sterile water in an amount of 100 ml;
- a sixth component comprising a 10% solution of sodium hydroxide in an amount of 7 GTTs (drops);
- and
- a seventh component comprising a 1% solution of Polysaccharide in an amount of 20 ml, wherein the 1% solution of Polysaccharide includes a gellan gum and a carrageenan;
- wherein the first, second, third, fourth, sixth and seventh components are added and dissolved in the fifth component to produce the liquid nasal spray composition.
Dependencies are inferred from the claim text.